Related references
Note: Only part of the references are listed.Comprehensive Metabolomics and Lipidomics Profiling of Prostate Cancer Tissue Reveals Metabolic Dysregulations Associated with Disease Development
Ana Rita Lima et al.
JOURNAL OF PROTEOME RESEARCH (2022)
Targeting cancer metabolism in the era of precision oncology
Zachary E. Stine et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss
Debora C. Bastos et al.
JOURNAL OF PATHOLOGY (2021)
The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis
Jacek Marzec et al.
CANCERS (2021)
Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming
Javier Marquez et al.
CANCERS (2021)
Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis
Otilia Menyhart et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2021)
CMBD: a manually curated cancer metabolic biomarker knowledge database
Jing Chen et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2021)
The Emerging Clinical Role of Spermine in Prostate Cancer
Qiang Peng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Interplay Between Prostate Cancer Genomics, Metabolism, and the Epigenome: Perspectives and Future Prospects
Reema Singh et al.
FRONTIERS IN ONCOLOGY (2021)
Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
Huan Xu et al.
METABOLITES (2021)
Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance
Joshua E. Lewis et al.
NATURE COMMUNICATIONS (2021)
Lipidomics as a Diagnostic Tool for Prostate Cancer
Magdalena Buszewska-Forajta et al.
CANCERS (2021)
Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics
Ana Rita Lima et al.
METABOLITES (2021)
Metabolic reprogramming in prostate cancer
Fahim Ahmad et al.
BRITISH JOURNAL OF CANCER (2021)
GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis
Daniel M. Kremer et al.
NATURE COMMUNICATIONS (2021)
Inflammatory metabolic profile of South African patients with prostate cancer
Stefano Cacciatore et al.
CANCER & METABOLISM (2021)
Metabolic drug survey highlights cancer cell dependencies and vulnerabilities
Tea Pemovska et al.
NATURE COMMUNICATIONS (2021)
Cancer metabolism: looking forward
Inmaculada Martinez-Reyes et al.
NATURE REVIEWS CANCER (2021)
NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer
Hong Zheng et al.
CLINICA CHIMICA ACTA (2020)
Development of cancer metabolism as a therapeutic target: new pathways, patient studies, stratification and combination therapy
Adrian L. Harris
BRITISH JOURNAL OF CANCER (2020)
Decreased glucose bioavailability and elevated aspartate metabolism in prostate cancer cells undergoing epithelial-mesenchymal transition
Yule Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Improving diagnosis of genitourinary cancers: Biomarker discovery strategies through mass spectrometry-based metabolomics
Malena Manzi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2020)
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer
Michael A. Kiebish et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Nuclear magnetic resonance spectroscopy of human body fluids and in vivo magnetic resonance spectroscopy: Potential role in the diagnosis and management of prostate cancer
Neda Gholizadeh et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Metabolic Reprogramming and Vulnerabilities in Cancer
Costas A. Lyssiotis et al.
CANCERS (2020)
Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery
Bongyong Lee et al.
SCIENTIFIC REPORTS (2020)
Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status
Ilona Dudka et al.
BMC CANCER (2020)
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer
Monika Oberhuber et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Metabolomics and Multi-Omics Integration: A Survey of Computational Methods and Resources
Tara Eicher et al.
METABOLITES (2020)
Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study
Hanna E. Rohnisch et al.
BMC MEDICINE (2020)
Human Prostate Cancer Is Characterized by an Increase in Urea Cycle Metabolites
Andras Franko et al.
CANCERS (2020)
Identification of plasma lipid species as promising diagnostic markers for prostate cancer
Xiaoli Chen et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2020)
Targeted Metabolomics Analyses Reveal Specific Metabolic Alterations in High-Grade Prostate Cancer Patients
Nuria Gomez-Cebrian et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Integration of Online Omics-Data Resources for Cancer Research
Tonmoy Das et al.
FRONTIERS IN GENETICS (2020)
CPT1A Over-Expression Increases Reactive Oxygen Species in the Mitochondria and Promotes Antioxidant Defenses in Prostate Cancer
Molishree Joshi et al.
CANCERS (2020)
Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model
Yanlong Zhang et al.
FRONTIERS IN ONCOLOGY (2020)
Moving Beyond Gleason Scoring
Brian Miles et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Metabolomic Heterogeneity of Urogenital Tract Cancers Analyzed by Complementary Chromatographic Techniques Coupled with Mass Spectrometry
Arlette Yumba-Mpanga et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Current Trends in Cancer Biottiarker Discovery Using Urinary Metabolomics: Achievements and New Challenges
Casey Burton et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
Beste Turanli et al.
EBIOMEDICINE (2019)
PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
Lisa Kaminski et al.
CANCER RESEARCH (2019)
Prostate biopsy: when and how to perform
C. J. Das et al.
CLINICAL RADIOLOGY (2019)
Multi-Omics Analyses Detail Metabolic Reprogramming in Lipids, Carnitines, and Use of Glycolytic Intermediates between Prostate Small Cell Neuroendocrine Carcinoma and Prostate Adenocarcinoma
Bei Gao et al.
METABOLITES (2019)
Systems Biology and Multi-Omics Integration: Viewpoints from the Metabolomics Research Community
Farhana R. Pinu et al.
METABOLITES (2019)
The applications of metabolomics in the molecular diagnostics of cancer
Pro Kit Cheung et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
Metabolomic, transcriptomic and genetic integrative analysis reveals important roles of adenosine diphosphate in haemostasis and platelet activation in non-small-cell lung cancer
Long T. Hoang et al.
MOLECULAR ONCOLOGY (2019)
Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
Ana Rita Lima et al.
BRITISH JOURNAL OF CANCER (2019)
PGC1α Suppresses Prostate Cancer Cell Invasion through ERRα Transcriptional Control
Lorea Valcarcel-Jimenez et al.
CANCER RESEARCH (2019)
Racial differences in distribution of fatty acids in prostate cancer and benign prostatic tissues
Xinchun Zhou et al.
LIPIDS IN HEALTH AND DISEASE (2019)
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program
David P. Labbe et al.
NATURE COMMUNICATIONS (2019)
Integration of metabolomic and transcriptomic data reveals metabolic pathway alteration in breast cancer and impact of related signature on survival
Xiao Luo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
Giorgia Zadra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers
Nuria Gomez-Cebrian et al.
METABOLITES (2019)
Metabolomics Biomarkers of Prostate Cancer: A Systematic Review
Marouane Kdadra et al.
DIAGNOSTICS (2019)
Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities
Giorgia Zadra et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Prostate biopsy: guidelines and evidence
Nicolai Huebner et al.
CURRENT OPINION IN UROLOGY (2018)
Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer
Yaping Shao et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
Leena Latonen et al.
NATURE COMMUNICATIONS (2018)
Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS
Ana Rita Lima et al.
SCIENTIFIC REPORTS (2018)
Metabolomic Prediction of Human Prostate Cancer Aggressiveness: Magnetic Resonance Spectroscopy of Histologically Benign Tissue
Lindsey A. Vandergrift et al.
SCIENTIFIC REPORTS (2018)
Landmarks in prostate cancer
Niranjan J. Sathianathen et al.
NATURE REVIEWS UROLOGY (2018)
Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma
Maria K. Andersen et al.
SCIENTIFIC REPORTS (2018)
Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy
Jie Yin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression
Marc Clos-Garcia et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters
Hideo Otsuki et al.
PROSTATE (2017)
Fatty acid synthase (FASN) as a therapeutic target in breast cancer
Javier A. Menendez et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer
Hui-Ming Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study
Pawel Derezinski et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia
Clara Perez-Rambla et al.
METABOLOMICS (2017)
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer
Amaia Zabala-Letona et al.
NATURE (2017)
Identification of SPOP related metabolic pathways in prostate cancer
Min Yan et al.
ONCOTARGET (2017)
Prospective serum metabolomic profile of prostate cancer by size and extent of primary tumor
Jiaqi Huang et al.
ONCOTARGET (2017)
The Metabolic Phenotype of Prostate Cancer
Eric Eidelman et al.
FRONTIERS IN ONCOLOGY (2017)
Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation
Matthew J. Roberts et al.
PROSTATE INTERNATIONAL (2017)
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Peder R. Braadland et al.
BRITISH JOURNAL OF CANCER (2017)
Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment
Rebeca San Martin et al.
CANCER RESEARCH (2017)
Targeting Metabolism for Cancer Therapy
Alba Luengo et al.
CELL CHEMICAL BIOLOGY (2017)
Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition
Julie A. Schmidt et al.
BMC MEDICINE (2017)
Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer
Wei-Dong Ni et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Multi-omics approaches to disease
Yehudit Hasin et al.
GENOME BIOLOGY (2017)
Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer
Shancheng Ren et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer
Sebastian Meller et al.
ONCOTARGET (2016)
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort
Jesse K. McKenney et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study
Tilman Kuehn et al.
BMC MEDICINE (2016)
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A. Ari Hakimi et al.
CANCER CELL (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Response of Degarelix treatment in human prostate cancer monitored by HR-MAS 1H NMR spectroscopy
Basetti Madhu et al.
METABOLOMICS (2016)
The metabolic co-regulator PGC1α suppresses prostate cancer metastasis
Veronica Torrano et al.
NATURE CELL BIOLOGY (2016)
A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer
May-Britt Tessem et al.
PLOS ONE (2016)
NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics
Deepak Kumar et al.
PROSTATE (2016)
Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies
Ana Rita Lima et al.
TRANSLATIONAL ONCOLOGY (2016)
Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences
Kui Yang et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer
Akash K. Kaushik et al.
NATURE COMMUNICATIONS (2016)
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer
Ailin Falkmo Hansen et al.
ONCOTARGET (2016)
Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer
Jia Li et al.
SCIENTIFIC REPORTS (2016)
Proteomic Upregulation of Fatty Acid Synthase and Fatty Acid Binding Protein 5 and Identification of Cancer- and Race-Specific Pathway Associations in Human Prostate Cancer Tissues
Jennifer S. Myers et al.
JOURNAL OF CANCER (2016)
Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers
Tik-Hung Tsoi et al.
PLOS ONE (2016)
Prostate Cancer Patients-Negative Biopsy Controls Discrimination by Untargeted Metabolomics Analysis of Urine by LC-QTOF: Upstream Information on Other Omics
M. A. Fernandez-Peralbo et al.
SCIENTIFIC REPORTS (2016)
Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments
Barrie Peck et al.
CANCER & METABOLISM (2016)
Metabolic control of epigenetics in cancer
Adam Kinnaird et al.
NATURE REVIEWS CANCER (2016)
Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
Guro F. Giskeodegard et al.
BRITISH JOURNAL OF CANCER (2015)
Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study
Alison M. Mondul et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study
Wiktoria Struck-Lewicka et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Metabolomics-Derived Prostate Cancer Biomarkers: Fact or Fiction?
Deepak Kumar et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer
Takayuki Goto et al.
PROSTATE (2015)
Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells
Ayesha A. Shafi et al.
ONCOTARGET (2015)
Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a case
Wei Liu et al.
SCIENTIFIC REPORTS (2015)
Gene expression profiles in prostate cancer: Identification of candidate non-invasive diagnostic markers
L. Mengual et al.
ACTAS UROLOGICAS ESPANOLAS (2014)
Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer
Morten Beck Rye et al.
BMC MEDICAL GENOMICS (2014)
Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants
Jian An et al.
CELL REPORTS (2014)
Potential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer
Jack Schalken et al.
THERAPEUTIC ADVANCES IN UROLOGY (2014)
Identification of New Genes Downregulated in Prostate Cancer and Investigation of Their Effects on Prognosis
Lokman Varisli
GENETIC TESTING AND MOLECULAR BIOMARKERS (2013)
Tissue metabolite profiling identifies differentiating and prognostic biomarkers for prostate carcinoma
Klaus Jung et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Metastatic Castration-Resistant Prostate Cancer Hungers for Leucine
Andrew R. Tee
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Targeting Amino Acid Transport in Metastatic Castration-Resistant Prostate Cancer: Effects on Cell Cycle, Cell Growth, and Tumor Development
Qian Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Quantitative Proteomics Reveals That Enzymes of the Ketogenic Pathway Are Associated with Prostate Cancer Progression
Punit Saraon et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Metabolomic profiling of lung and prostate tumor tissues by capillary electrophoresis time-of-flight mass spectrometry
Kenjiro Kami et al.
METABOLOMICS (2013)
Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways
Chunquan Li et al.
NUCLEIC ACIDS RESEARCH (2013)
Serum Glucose and Fructosamine in Relation to Risk of Cancer
Wahyu Wulaningsih et al.
PLOS ONE (2013)
Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness
Guro F. Giskeodegard et al.
PLOS ONE (2013)
Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer
Diederick Duijvesz et al.
PLOS ONE (2013)
Malate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism
Qiong Liu et al.
PROSTATE (2013)
Metabolomic signatures of aggressive prostate cancer
Jonathan E. McDunn et al.
PROSTATE (2013)
Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer
J. L. Wright et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2013)
Adenocarcinoma on needle prostatic biopsies: Does reactive stroma predicts biochemical recurrence in patients following radical prostatectomy?
Athanase Billis et al.
INTERNATIONAL BRAZ J UROL (2013)
The Role of Sarcosine Metabolism in Prostate Cancer Progression
Amjad P. Khan et al.
NEOPLASIA (2013)
Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer
S. Kojima et al.
BRITISH JOURNAL OF CANCER (2012)
Candidate Serum Biomarkers for Prostate Adenocarcinoma Identified by mRNA Differences in Prostate Tissue and Verified with Protein Measurements in Tissue and Blood
Eric W. Klee et al.
CLINICAL CHEMISTRY (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
Functional Metabolic Screen Identifies 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 4 as an Important Regulator of Prostate Cancer Cell Survival
Susana Ros et al.
CANCER DISCOVERY (2012)
Oxidative stress adaptation in aggressive prostate cancer may be counteracted by the reduction of glutathione reductase
Mariana Freitas et al.
FEBS OPEN BIO (2012)
Nuclear Magnetic Resonance-Based Metabolomics Enable Detection of the Effects of a Whole Grain Rye and Rye Bran Diet on the Metabolic Profile of Plasma in Prostate Cancer Patients
Ali A. Moazzami et al.
JOURNAL OF NUTRITION (2011)
Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation
Seung-Jin Kim et al.
MOLECULES AND CELLS (2011)
Molecular classification of prostate cancer using curated expression signatures
Elke K. Markert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Prostate Cancer Early Detection
Mark H. Kawachi et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
Metabolomic Characterization of Human Prostate Cancer Bone Metastases Reveals Increased Levels of Cholesterol
Elin Thysell et al.
PLOS ONE (2010)
Retrospective Analysis of Prostate Cancer Recurrence Potential With Tissue Metabolomic Profiles
Andreas Maxeiner et al.
PROSTATE (2010)
Intensity of stromal changes predicts biochemical recurrence-free survival in prostatic carcinoma
Davor Tomas et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2010)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar et al.
NATURE (2009)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions
Natalie J. Serkova et al.
PROSTATE (2008)
Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues
Andrew C. Goodwin et al.
PROSTATE (2008)
Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy
Nobuyuki Yanagisawa et al.
HUMAN PATHOLOGY (2007)
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma
US Shah et al.
HUMAN PATHOLOGY (2006)
High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB
T Van de Sande et al.
JOURNAL OF PATHOLOGY (2005)
Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer
JV Swinnen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T
LL Cheng et al.
FEBS LETTERS (2001)
Share Paper
